Characteristics of long-term survivors with malignant pleural mesothelioma

January 15, 2025 | Comments Off on Characteristics of long-term survivors with malignant pleural mesothelioma

The Annals of Thoracic Surgery 2024 October 22 [Link] Isabelle Opitz, Olivia Lauk, Raphael Werner, Alessandra Matter, Monika Hebeisen, Bianca Battilana, Hasan Batirel, Harvey Pass, Raja Flores, Andrea Wolf, Marc…

Activation of platelet-derived growth factor receptors regulate connective tissue growth factor protein levels via the AKT pathway in malignant mesothelioma cells

January 14, 2025 | Comments Off on Activation of platelet-derived growth factor receptors regulate connective tissue growth factor protein levels via the AKT pathway in malignant mesothelioma cells

Journal of Biochemistry 2024 December 2 [Link] Tomoya Suehiro, Khoja Mouhand Ahmad, Nguyen Truong Duc Hoang, Bingwen Xu, Honoka Komatsu, Komei Kurachi, Hiroki Nikawa, Yuichi Mine, Tohru Matsuki, Katsura Asano,…

Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case report

January 13, 2025 | Comments Off on Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case report

Translational Lung Cancer Research 2024 September 30 [Link] Gaspard Naulleau, Isabelle Monnet, Gaëlle Rousseau-Bussac, Florent Vinas, Gilles Mangiapan, Laurence Jabot, Amel Boudjemaa, Christos Chouaïd, Jean-Bernard Auliac, Jean-Baptiste Assié Abstract Background:…

Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma

January 10, 2025 | Comments Off on Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma

Translational Lung Cancer Research 2024 September 30 [Link] Linda Ye, Heeju Ryu, David Granadier, Long T Nguyen, Yannick Simoni, Ian Dick, Tina Firth, Ebony Rouse, Peter Chiang, Y C Gary…

Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM)

January 9, 2025 | Comments Off on Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM)

Clinical Lung Cancer 2024 December [Link] Diego Enrico, Juan Elias Gomez, Danilo Aguirre, Natalia Soledad Tissera, Florencia Tsou, Carmen Pupareli, Delfina Peralta Tanco, Federico Waisberg, Andrés Rodríguez, Manglio Rizzo, Nicolás…

Systemic Therapy Options for Peritoneal Mesothelioma

January 8, 2025 | Comments Off on Systemic Therapy Options for Peritoneal Mesothelioma

Journal of the Comprehensive Cancer Network 2024 October [Link] Tawee Tanvetyanon, George R Simon Abstract Peritoneal mesothelioma is an uncommon malignancy affecting approximately 300 new patients annually in the United…

High endothelial venules in the pleura: MECA-79 expression in mesothelioma, pleural metastasis and pleuritis

January 7, 2025 | Comments Off on High endothelial venules in the pleura: MECA-79 expression in mesothelioma, pleural metastasis and pleuritis

Pathology, Research, and Practice 2024 November [Link] Ikram Kherrour, Mousa Mobarki, Michel Péoc’h, Georgia Karpathiou Abstract Introduction: High endothelial venules (HEVs) are vessels specialized in the extravasation of lymphocytes from…

Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model

January 6, 2025 | Comments Off on Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model

Cancer Immunology, Immunotherapy 2025 January 3 [Link] Rebecca A D’Alonzo, Synat Keam, Suki Gill, Pejman Rowshanfarzad, Anna K Nowak, Martin A Ebert, Alistair M Cook Abstract Combination immune checkpoint inhibitors…

Gender- and Age-Based Characterization and Comparison of the Murine Primary Peritoneal Mesothelial Cell Proteome

January 3, 2025 | Comments Off on Gender- and Age-Based Characterization and Comparison of the Murine Primary Peritoneal Mesothelial Cell Proteome

bioRxiv 2024 October 11 [Link] Zhikun Wang, Yueying Liu, Reihaneh Safavisohi, Marwa Asem, Daniel D Hu, Mary Sharon Stack, Matthew M Champion Abstract Organs in the abdominal cavity are covered…

Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies

January 2, 2025 | Comments Off on Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies

International Journal of Molecular Sciences 2024 October 9 [Link] Lauren Chiec, Debora S Bruno Abstract Pleural mesothelioma is a rare malignancy associated with asbestos exposure and very poor prognosis, with…

Categories